Dengue Program Leader
Dr. Shilpi Jain joined DNDi as Dengue Program Leader. She brings over 20 years of experience in drug development, clinical strategy and global clinical operations across the pharmaceutical and biotechnology sectors, with expertise spanning innovative drugs, complex and differentiated generics, and vaccines. She has contributed to clinical development programmes from early-phase research through Phase III across India, the USA and other international markets.
Prior to joining DNDi, Shilpi held leadership positions at Dr. Reddy’s Laboratories, Panacea Biotec, Zydus Cadila and Vyome Therapeutics, where she contributed to clinical development strategy, global clinical trials, regulatory submissions and strategic drug development initiatives. Her contributions to vaccine development include WHO-supported clinical trials supporting polio eradication efforts in India and vaccine prequalification programmes. She has co-authored multiple peer-reviewed scientific publications.
Get our latest news, personal stories, research articles, and job opportunities.